🔎 Trials Near Me

Hjem › Seglcelle-anæmi › Texas › Houston

Seglcelle-anæmi kliniske forsøg i Houston, TX

10 studier for Seglcelle-anæmi søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

RekruttererFase 3
  • Texas Childrens Cancer and Hematology Center, Houston
  • U of TX Health Science Ct, Houston
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

RekruttererFase 3
  • Texas Children's Hospital_Houston, Houston
  • UT Health University of Texas, Houston
Alder 2 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

RekruttererFase 3
  • UT Health University of Texas, Houston
Alder 12 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
  • UT Health Science Center, Houston
Alder 12 til 55 · Alle køn · Opdateret 9. sep. 2026 · NCT06546670

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

RekruttererObservationsstudie
  • Gulf States Hemophilia and Thrombophilia Center, Houston
  • Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

RekruttererFase 3
  • Baylor College of Medicine- Site Number : 8400055, Houston
Alder 10 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT06975865

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

RekruttererObservationsstudie
  • Texas Children's Hopsital (NT-DMT), Houston
  • Texas Children's Hospital (MRD-HCT), Houston
Alder 3 til 20 · Alle køn · Opdateret 4. jun. 2026 · NCT06941389

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

RekruttererFase 3
  • Site # 8400004, Houston
Alder 2 til 17 · Alle køn · Opdateret 15. apr. 2026 · NCT07247188

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

RekruttererFase 2
  • Baylor College of Medicine, Houston
Alder 15 til 40 · Alle køn · Opdateret 13. mar. 2026 · NCT06260891

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

RekruttererObservationsstudie
  • University of Texas at Houston, Houston
Alder 18 og opefter · Alle køn · Opdateret 22. jun. 2025 · NCT06385886

Seglcelle-anæmi forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.